Biogen’s Antibody Lupus Treatment Shows Mid-Stage Promise

Biogen’s Antibody Lupus Treatment Shows Mid-Stage Promise

Source: 
BioSpace
snippet: 

Biogen announced that its mid-stage monoclonal antibody, litifilimab, is showing promise in reducing joint pain related to systemic lupus erythematosus (SLE) lupus.